Key Events This Week
24 Aug: Stock opens at Rs.0.51, declines 1.92%
25 Aug: Hits all-time low of Rs.0.50 amid prolonged downtrend
26 Aug: Falls further to 52-week low of Rs.0.49 despite Sensex gains
27 Aug: Price stabilises at Rs.0.51 with no change
28 Aug: Week closes at Rs.0.50, down 1.96% on the day
24 August 2026: Week Opens with Decline Amid Market Weakness
Shree Ganesh Biotech India Ltd began the week at Rs.0.51, down 1.92% from the previous close of Rs.0.52. The stock’s volume was moderate at 454,049 shares. The Sensex also declined slightly by 0.12% to 36,770.21, reflecting a cautious market sentiment. The stock’s early weakness foreshadowed the challenging week ahead, as it remained below key moving averages and under pressure from ongoing financial concerns.
25 August 2026: All-Time Low of Rs.0.50 Highlights Prolonged Downtrend
On 25 August, the stock hit a new all-time low of Rs.0.50, marking a significant milestone in its extended decline. This represented a 36.25% drop from its 52-week high of Rs.0.80. Despite the broader market’s positive movement, with the Sensex rising 0.36% to 36,901.03, Shree Ganesh Biotech’s shares underperformed sharply. The volume surged to 1,165,789 shares, indicating increased trading activity amid the downtrend.
Financial metrics remain weak, with the company reporting negative EBITDA of Rs.-1.76 crores and quarterly PBDIT and PBT at Rs.-0.89 crores. The Mojo Score stands at 12.0 with a Strong Sell rating, reflecting deteriorated fundamentals and limited investor confidence. Technical indicators confirm bearish momentum, with the stock trading below all major moving averages and key support at Rs.0.50.
Our latest monthly pick, this Small Cap from Oil Exploration/Refineries, is showing strong performance since announcement! See why our Investment Committee chose it after screening 50+ candidates.
- - Investment Committee approved
- - 50+ candidates screened
- - Strong post-announcement performance
26 August 2026: New 52-Week Low of Rs.0.49 Amidst Market Divergence
The stock declined further to Rs.0.49, establishing a fresh 52-week and all-time low. This represented a 38.75% fall from the 52-week high and a 2.00% intraday gain was insufficient to offset the overall negative trend. The Sensex, in contrast, advanced by 0.4% to 36,890.31, supported by gains in mega-cap stocks and midcap indices hitting new highs.
Technical indicators remained bearish, with the Moving Average Convergence Divergence (MACD) and KST signalling sustained downward momentum. The stock’s delivery volumes increased by over 60% compared to the five-day average, reflecting heightened trading activity despite the downtrend. The company’s financials continue to show strain, with negative EBITDA and minimal earnings per share of Rs.-0.01 for the quarter ending June 2026.
27 August 2026: Price Stabilises at Rs.0.51 on Lower Volume
On 27 August, the stock price stabilised at Rs.0.51, showing no change from the previous close. However, volume dropped significantly to 228,026 shares. The Sensex declined by 0.52% to 36,700.18, reflecting broader market weakness. Despite the price stability, the stock remains below all key moving averages, and technical indicators continue to signal bearish momentum.
Why settle for Shree Ganesh Biotech India Ltd? SwitchER evaluates this micro-cap against peers, other sectors, and market caps to find you superior investment opportunities!
- - Comprehensive evaluation done
- - Superior opportunities identified
- - Smart switching enabled
28 August 2026: Week Closes Lower at Rs.0.50 Despite Sensex Recovery
The week ended with the stock closing at Rs.0.50, down 1.96% on the day and 3.85% for the week. Volume was subdued at 173,113 shares. The Sensex rebounded by 0.26% to 36,794.04, highlighting the stock’s continued underperformance relative to the benchmark. The company’s micro-cap status, weak financial metrics, and bearish technical outlook continue to weigh on investor sentiment.
| Date | Stock Price | Day Change | Sensex | Day Change |
|---|---|---|---|---|
| 2026-08-24 | Rs.0.51 | -1.92% | 36,770.21 | -0.12% |
| 2026-08-25 | Rs.0.50 | -1.96% | 36,901.03 | +0.36% |
| 2026-08-26 | Rs.0.51 | +2.00% | 36,890.31 | -0.03% |
| 2026-08-27 | Rs.0.51 | +0.00% | 36,700.18 | -0.52% |
| 2026-08-28 | Rs.0.50 | -1.96% | 36,794.04 | +0.26% |
Key Takeaways
Shree Ganesh Biotech India Ltd’s stock performance this week underscores a continuation of its prolonged downtrend, with the share price hitting new all-time and 52-week lows at Rs.0.50 and Rs.0.49 respectively. The stock’s 3.85% weekly decline starkly contrasts with the near-flat movement of the Sensex, which fell only 0.05%, highlighting company-specific challenges rather than broader market weakness.
Financially, the company remains under pressure with negative EBITDA of Rs.-1.76 crores and minimal earnings per share of Rs.-0.01, reflecting ongoing losses and subdued profitability. The Mojo Score of 12.0 and Strong Sell rating reinforce the weak fundamental outlook. Technical indicators remain bearish, with the stock trading below all major moving averages and key support levels tested during the week.
Increased delivery volumes and trading activity suggest heightened investor attention, yet the micro-cap status and low institutional holding of 1.42% limit liquidity and market confidence. The divergence between the stock’s performance and sector or benchmark indices further emphasises company-specific headwinds.
Conclusion
The week ending 28 August 2026 has been challenging for Shree Ganesh Biotech India Ltd, with the stock declining 3.85% and setting fresh lows amid persistent financial and technical weakness. Despite a broadly stable Sensex, the company’s shares continue to reflect underlying operational difficulties and investor caution. The Strong Sell rating and low Mojo Score highlight the severity of the situation, with limited signs of near-term recovery. Investors should note the ongoing downtrend and subdued fundamentals as key factors shaping the stock’s outlook.
Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →
